Incidence of Cardiovascular Disease Higher for Seniors With Cancer

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 23, 2024.

By Elana Gotkine HealthDay Reporter

MONDAY, Sept. 23, 2024 -- The incidence of a composite cardiovascular disease (CVD) end point is increased among older adults with cancer, especially those with metastatic, hematological, and lung cancer, according to a study published online Sept. 23 in Cancer.

Jaidyn Muhandiramge, M.D., from Monash University in Melbourne, Australia, and colleagues conducted a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial to examine the impact of cancer and cancer treatment on a composite CVD end point. Overall, 1,392 of the 15,454 Australian and U.S. ASPREE participants had a cancer diagnosis.

The researchers observed greater rates of CVD in the cancer risk-set versus the cancer-free risk-set (20.8 versus 10.3 events per 1,000 person-years; incidence rate ratio, 2.03); increased incidence was seen for myocardial infarction, hospitalization for heart failure, overall stroke, and ischemic stroke. After adjustment for clinically significant risk factors for CVD, the increased incidence persisted. The greatest incidence was seen for metastatic, hematological, and lung cancer. An increased risk for CVD was seen in association with chemotherapy. Across aspirin and placebo groups, the rates of CVD were similar.

"The clinical implications of our findings lie in the impact of CVD on mortality and the fact that with appropriate screening and management, cardiovascular risk in cancer survivors can be mitigated," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords